Cargando…

Vasopressor Therapy and the Brain: Dark Side of the Moon

Sepsis, a leading cause of morbidity and mortality, is caused by a deregulated host response to pathogens, and subsequent life-threatening organ dysfunctions. All major systems, including the cardiovascular, respiratory, renal, hepatic, hematological, and the neurological system may be affected by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Heming, Nicholas, Mazeraud, Aurélien, Azabou, Eric, Moine, Pierre, Annane, Djillali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966606/
https://www.ncbi.nlm.nih.gov/pubmed/31998736
http://dx.doi.org/10.3389/fmed.2019.00317
_version_ 1783488774732251136
author Heming, Nicholas
Mazeraud, Aurélien
Azabou, Eric
Moine, Pierre
Annane, Djillali
author_facet Heming, Nicholas
Mazeraud, Aurélien
Azabou, Eric
Moine, Pierre
Annane, Djillali
author_sort Heming, Nicholas
collection PubMed
description Sepsis, a leading cause of morbidity and mortality, is caused by a deregulated host response to pathogens, and subsequent life-threatening organ dysfunctions. All major systems, including the cardiovascular, respiratory, renal, hepatic, hematological, and the neurological system may be affected by sepsis. Sepsis associated neurological dysfunction is triggered by multiple factors including neuro-inflammation, excitotoxicity, and ischemia. Ischemia results from reduced cerebral blood flow, caused by extreme variations of blood pressure, occlusion of cerebral vessels, or more subtle defects of the microcirculation. International guidelines comprehensively describe the initial hemodynamic management of sepsis, revolving around the normalization of systemic hemodynamics and of arterial lactate. By contrast, the management of sepsis patients suffering from brain dysfunction is poorly detailed, the only salient point being mentioned is that sedation and analgesia should be optimized. However, sepsis and the hemodynamic consequences thereof as well as vasopressors may have severe untoward neurological consequences. The current review describes the general neurological complications, as well as the consequences of vasopressor therapy on the brain and its circulation and addresses methods for cerebral monitoring during sepsis.
format Online
Article
Text
id pubmed-6966606
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69666062020-01-29 Vasopressor Therapy and the Brain: Dark Side of the Moon Heming, Nicholas Mazeraud, Aurélien Azabou, Eric Moine, Pierre Annane, Djillali Front Med (Lausanne) Medicine Sepsis, a leading cause of morbidity and mortality, is caused by a deregulated host response to pathogens, and subsequent life-threatening organ dysfunctions. All major systems, including the cardiovascular, respiratory, renal, hepatic, hematological, and the neurological system may be affected by sepsis. Sepsis associated neurological dysfunction is triggered by multiple factors including neuro-inflammation, excitotoxicity, and ischemia. Ischemia results from reduced cerebral blood flow, caused by extreme variations of blood pressure, occlusion of cerebral vessels, or more subtle defects of the microcirculation. International guidelines comprehensively describe the initial hemodynamic management of sepsis, revolving around the normalization of systemic hemodynamics and of arterial lactate. By contrast, the management of sepsis patients suffering from brain dysfunction is poorly detailed, the only salient point being mentioned is that sedation and analgesia should be optimized. However, sepsis and the hemodynamic consequences thereof as well as vasopressors may have severe untoward neurological consequences. The current review describes the general neurological complications, as well as the consequences of vasopressor therapy on the brain and its circulation and addresses methods for cerebral monitoring during sepsis. Frontiers Media S.A. 2020-01-10 /pmc/articles/PMC6966606/ /pubmed/31998736 http://dx.doi.org/10.3389/fmed.2019.00317 Text en Copyright © 2020 Heming, Mazeraud, Azabou, Moine and Annane. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Heming, Nicholas
Mazeraud, Aurélien
Azabou, Eric
Moine, Pierre
Annane, Djillali
Vasopressor Therapy and the Brain: Dark Side of the Moon
title Vasopressor Therapy and the Brain: Dark Side of the Moon
title_full Vasopressor Therapy and the Brain: Dark Side of the Moon
title_fullStr Vasopressor Therapy and the Brain: Dark Side of the Moon
title_full_unstemmed Vasopressor Therapy and the Brain: Dark Side of the Moon
title_short Vasopressor Therapy and the Brain: Dark Side of the Moon
title_sort vasopressor therapy and the brain: dark side of the moon
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966606/
https://www.ncbi.nlm.nih.gov/pubmed/31998736
http://dx.doi.org/10.3389/fmed.2019.00317
work_keys_str_mv AT hemingnicholas vasopressortherapyandthebraindarksideofthemoon
AT mazeraudaurelien vasopressortherapyandthebraindarksideofthemoon
AT azaboueric vasopressortherapyandthebraindarksideofthemoon
AT moinepierre vasopressortherapyandthebraindarksideofthemoon
AT annanedjillali vasopressortherapyandthebraindarksideofthemoon